Skip to main content
. 2022 May 6;2022:6806932. doi: 10.1155/2022/6806932

Table 2.

Demographics of the 45 patients with metastatic LMS to bone.

Demographics N (%)
Sex
 Female 31 (69%)
 Male 14 (31%)
Age (years)
Race
 Caucasian 33 (73.3%)
 African American 10 (22.2%)
 Other 2 (4.4%)
LMS subtype
 Uterine 18 (40%)
 Retroperitoneal 15 (33%)
 Extremity soft tissue 8 (18%)
 H&N 1 (2.2%)
 Lung 1 (2.2%)
 Unknown 2 (4.4%)
Visceral metastases 42 (93%)
Median survival time (months, IQR) 60 (37.2, 100)